ContraVir’s CMX157 shows 99% drop in HBV viral load. Nucleoside analogues, or NUCs, look to be the cure. Risks involve if drugs work in bigger clinical trials;

http://seekingalpha.com/article/4012524-contravirs-promising-new-nuc-drug-may-eradicate-hepatitis